High bone turnover is associated with low bone mass in both pre- and postmenopausal women

Bone

Volumn 19, Issue 3, 1996, Pages 291-298

  Ravn, Pernille ^a   Fledelius, C ^b   Rosenquist, C ^b   Overgaard, K ^a   Christiansen, C ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^b NORDIC BIOSCIENCE A S   (Denmark)

Author keywords

Bone formation; Bone mass; Bone resorption; Postmenopausal women; Premenopausal women

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; HYDROXYPROLINE; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BONE MASS; BONE TURNOVER; COLLAGEN DEGRADATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR; FOREARM; HUMAN; HUMAN EXPERIMENT; HYDROXYPROLINE URINE LEVEL; LUMBAR SPINE; MENOPAUSE; NORMAL HUMAN; URINE;

EID: 0030247030     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(96)00201-3     Document Type: Article

References (37)

1. 1. Appleyard, M. The Copenhagen City heart study-Østerbroundersøgelsen. Scand J Soc Med (Suppl.)41:81-93; 1987.
2. 2. Bjarnason, K., Hassager, C., Ravn, P., and Christiansen, C. Early postmenopausal diminution of forearm and spinal bone mineral density. A cross-sectional study. Osteopor Int 5:35-38; 1995.
3. 3. Body, J. J, and Delmas, P. D. Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcaemia. J Clin Endocrinol Metab 74:471-475; 1992.
4. 4. Bonde, M., Qvist, P., Fledelius, C., Riis, B. J., and Christiansen, C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 40:2022-2025; 1994.
5. 5. Bonde, M., Qvist, P., Fledelius, C., Riis, B. J., and Christiansen, C. Applications of an enzyme immunoassay for a new marker of bone resorption (Cross-Laps™)-Follow up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 80:864-868; 1995.
6. 6. Borg, J., Møllgaard, A., and Riis, B. J. Single x-ray absorptiometry: Performance characteristics and comparison with single photon absorptiometry. Osteopor Int 5:377-381; 1995.
7. 7. Brown, J. P., Delmas, P. D., Malaval, L., Edouard, C., Chapuy, M. C., and Meunier, P. J. Serum bone Gla-protein: A specific marker for bone formation in postmenopausal osteoporosis. Lancet May 19:1091-1093; 1984.
8. 8. Christiansen, C., Riis, B. J., and Rødbro, P. Prediction of rapid bone loss in postmenopausal women. Lancet i:1105-1108; 1987.
9. 9. Christiansen, C., Riis, B. J., and Rødbro, P. Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteoporosis Int 1:35-40; 1990.
10. 10. Delmas, P. D. Biochemical markers of bone turnover. J Bone Miner Res (Suppl.)2:S49-S55; 1993.
11. 11. Ebeling, P. R., Atley, L. M., Eyre, D. R., Guthrie, J., Dennerstein, L., and Wark, J. D. Sensitivity of collagen cross-links and osteocalcin in detecting early menopausal changes in bone turnover. In Christiansen, C., Ed. Fourth International Symposium on Osteoporosis. Hong Kong: Gardiner; 1993; Abstract 580.
12. 12. Eyre, D. R., Koob, T. J., and Van Ness, K. P. Quantitation of hydroxypyridinium cross-links in collagen by high performance liquid chromatography. Anal Biochem 137:380-388; 1984.
13. 13. Eyre, D. R. New biomarkers of bone resorption (editorial). J Clin Endocrinol Metab 74:470A-470C; 1992.
14. 14. Gambacciani, M., Spinetti, A., Taponeco, F., Cappagli, B., Maffei, S., Manetti, P., Piagessi, L., and Fioretti, P. Bone loss in perimenopausal women: A longitudinal study. Maturitas 18:191-197; 1994.
15. 15. Garnero, P., Gineyts, E., Riou, J. P., and Delmas, P. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 79:780-785; 1994.
16. 16. Garnero, P., Weichung, J. S., Gineyts, E., Karpf, D. B., and Delmas, P.D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate therapy. J Clin Endocrinol Metab 79:1693-1700; 1994.
17. 17. Garnero, P., Gineyts, E., Arbault, P., Christiansen, C., and Delmas, P. D. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 10:641-649; 1995.
18. 18. Garnero, P., Sornay-Rendu, E., Chapuy, M-C., and Delmas, P. D. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337-349; 1996.
19. 19. Gertz, B. J., Shao, P., Hanson, D, A., Quan, H., Harris, S. T., Genant, H. K., Chesnut, C. H., III, and Eyre, D. R. Monitoring bone reacute;sorption in early postmenopausal women by an imrnunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 9:135-142; 1994.
20. 20. Hansen, M. A., Hassager, C., Overgaard, K., Marslew, U., Riis, B. J., and Christiansen, C. Dual-energy x-ray absorptiometry: A precise method of measuring bone mineral density in the lumbar spine. J Nucl Med 31:1156-1162; 1990.
21. 21. Hansen, M., Overgaard, K., Riis, B. J., and Christiansen, C. Role of peak bone mass and bone loss in postrnenopausal osteoporosis: 12 year study. Br Med J 303:961-964; 1991.
22. 22. Hanson, D. A., Weis, M. A. E., Bollen, A.-M. Maslan, S. L., Singer, F. R., and Eyre, D. R. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 7:1251-1258; 1992.
23. 23. Hashimoto, K., Nozaki, M., Yokoyama, M., Sano, M., and Nakano, H. Urinary excretion of pyridinium cross-links of collagen in oophorectomized women as markers for bone resorption. Maturitas 18:132-142; 1994.
24. 24. Kivirikko, K. I. Urinary excretion of hydroxyproline in health and disease. Int Rev Connect Tissue Res 5:93-163; 1970.
25. 25. Mazess, R. B. and Barden, H. S. Bone density in premenopausal women: Effects of age, dietary intake, physical activity, smoking, and birth control pills. Am J Clin Nutr. 53:132-142; 1991.
26. 26. Moss, D, W. Alkaline phosphatase isoenzymes. Clin Chem 28:2007-2016; 1992.
27. 27. Ohta, H., Ikeda, T., Masuzawa, T., Makita, K., Suda, Y., and Nozawa, S. Differences in axial bone mineral density, serum levels of sex steroids, and bone metabolism between postmenopausal and age-and body size-matched premenopausal subjects. Bone 14:111-116; 1993.
28. 28. Ravn, P., Hetland, M. L., Overgaard, K., and Christiansen, C. Pre-and postmenopausal changes in bone mineral density of the proximal femur measured by dual energy x-ray absorptiometry. J Bone Miner Res 9:1975-1980; 1994.
29. 29. Reid, I. R., Ames, R., Evans, M. C., Sharpe, S., Gamble, G., France, J. T., Lim, T. M. T., and Cundy, T. F. Determinants of total body and regional bone mineral density in normal postmenopausal women - A key role for fat mass. J Clin Endocrinol Metab 75:45-51; 1992.
30. 30. Risteli, J., Elonaa, I., Niemi, S., Novamo, A., and Risteli, L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39:635-640; 1993.
31. 31. Rosenquist, C., Qvist, P., Bjarnason, N., and Christiansen, C. Measurement of a more stable structure of osteocalcin in human serum using two monoclonal antibodies in an enzyme-linked immunosorbent assay (ELISA). Clin Chem 41:1439-1445; 1995.
32. 32. SAS Institute. SAS/STAT guide for personal computers, version 6. Gary: SAS Institute, 1987,
33. 33. Seyedin, E. M., Kung, V. T., Daniloff, Y. N., Hesley, R. P., Gomez, B., and Nielsen, L. A., et al. et al. Immunoassay for urinary pyridinoline: The new marker for bone resorption. J Bone Miner Res 8:635-641; 1993.
34. 34. Sowers, M. R., Clark, M. K., Mollis, B., Wallace, R. B., and Jannausch, M. Radial bone mineral density in pre-and perimenopausal women: A prospective study of rates and risk factors for loss. J Bone Miner Res 7:647-657; 1992.
35. 35. Stepan, J. J., Pospichal, J., Presl, J., and Pacowsky, V. Bone loss and biochemical indices of bone remodelling in surgically induced postmenopausal women. Bone 8:279-284; 1987.
36. 36. Uebelhart, D., Gineyts, E., Chapeuy, M.-C., and Delmas, P. D. Urinary excretion of pyridinium cross links: A new marker of bone resorption in metabolic bone disease. Bone Miner 8:87-96; 1990.
37. 37. Uebelhart, D., Schlemmer, A., Johansen, J. S., Gineyts, E., Christiansen, C., and Delmas, P. D, Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 72:367-373; 1991.